Bone Diseases
Paget Disease of Bone
aka Osteitis Deformans
Chronic disorder of accelerated, disorganised bone remodelling; jaw involvement causes progressive symmetrical enlargement, hypercementosis and denture non-fit.
§ overviewOverview
Focal or multifocal disorder of bone remodelling characterised by increased and disorganised osteoclastic resorption followed by exuberant, disorganised osteoblastic bone formation.
§ icdICD Classification
M88
§ etiologyEtiology
- 01Multifactorial: genetic (SQSTM1 mutation), possible paramyxovirus trigger
- 02First-degree relatives 7× risk
§ epidemiologyEpidemiology
Adults >55 y; slight male predominance; higher prevalence in UK, Australia, New Zealand.
§ pathogenesisPathogenesis
Three phases: lytic (osteoclast-mediated) → mixed → sclerotic; disorganised bone is mechanically weak but hypervascular.
§ clinicalClinical Features
- 01Progressive bone pain, deformity
- 02Enlarging cranial vault (hat size increases)
- 03Bilateral symmetrical jaw enlargement, spacing of teeth, denture becomes tight
- 04Deafness (cranial nerve VIII compression)
- 05High-output cardiac failure (rare)
§ radiographicRadiographic Features
- 01Skull: 'cotton wool' patchy sclerosis
- 02Jaw: hypercementosis, obliteration of PDL, loss of lamina dura
- 03Ground-glass and mixed radiolucent-radiopaque appearance
§ labsLaboratory Findings
- 01Markedly elevated serum alkaline phosphatase (isolated)
- 02Normal calcium, phosphate, PTH
- 03Increased urinary hydroxyproline and N-telopeptides
§ treatmentTreatment
- 01Asymptomatic: monitor
- 02Symptomatic: bisphosphonates (single-dose IV zoledronate preferred) — normalises ALP
- 03Calcitonin (second line)
- 04Analgesia, orthopaedic surgery for fractures
- 05Dental: extractions difficult (dense bone, hypercementosis, bleeding); avoid elective surgery in active phase
§ complicationsComplications
- 01Pathological fracture
- 02Osteosarcoma (<1% but grim prognosis)
- 03Cranial nerve palsies
- 04Post-extraction haemorrhage or osteomyelitis
§ prognosisPrognosis
Generally good with bisphosphonate therapy; new hearing loss or increased pain warrants imaging to exclude sarcoma.
§ examKey Examination Points
- 01Enlarging skull, ill-fitting dentures, isolated ALP rise
§ revisionQuick Revision Summary
- 01Cotton-wool skull · isolated ALP · zoledronate
§ vivaBDS Viva Questions
- 01Biochemical marker of Paget?
- 02Complications of extractions in Paget?
- 03Malignant transformation risk?
§ mcqsMCQs — Assessment (3)
Question 1
Classic biochemical finding:
Question 2
First-line pharmacotherapy:
Question 3
Malignant transformation to:
References
- Ralston SH. NEJM 2013
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.